Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 27, 2024Journal of Translational MedicineOpen Access

Identification of epigenetic silencing of the SFRP2 gene in colorectal cancer as a clinical biomarker and molecular significance

View Full Paper
Ask AI
Bookmark
Share

Authors

HBHatim BoughanemJPJesús PiloLGLibia Alejandra García-Flores

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Boughanem et al. (2024) studied this question.

synapsesocial.com/papers/68e6848db6db64358760ce7ahttps://doi.org/10.1186/s12967-024-05329-x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Circulating SFRP5 levels are elevated in colorectal cancer and correlate with overall survival in stage II-III disease2024
  2. 2Frequent Inactivation of Secreted Frizzled-Related Protein 2 during the Development of Cervical Carcinoma: Identification of Susceptible Alleles and Clinical Implications2024
  3. 3Expression Pattern of PDE4B, PDE4D, and SFRP5 Markers in Colorectal Cancer2024 · 3 citations
  4. 4Identification of Potent SFRP1 Inhibitors for Colorectal Cancer using a Comprehensive Computational Approach2024
  5. 5Application and evaluation of fecal SDC2 gene methylation in the diagnosis and treatment of colorectal cancer.2024